中国药理学会药物临床试验专业委员会简介

作者:管理员    发布于:2013-07-15

 中国药理学会药物临床试验专业委员会致力于药物临床试验运行管理体系的构建及学术、技术交流,汇集了国内药物临床试验研究领域的主要学科带头人及富有经验的一线工作者。通过搭建这个平台,有利于各研究机构交流与分享药物临床试验运行管理的宝贵经验,完善我国药物临床试验质量管理体系,打造与国际接轨的药物临床试验研究与评价技术体系,加强彼此合作,共同促进我国药物临床试验的进步与发展。
  药物临床试验专业委员会将采用不同形式,组织各方人士围绕药物临床试验与评价新技术、新方法、药物临床试验运行管理等方面展开学术研讨,共同探寻适合于我国药物临床试验机构运行管理的模式,促进我国药物临床试验运行的科学化与规范化,搭建与国际接轨的药物临床试验平台;整合药物临床试验机构优势资源,促进机构间的合作和资源共享;发挥专家特长,协助国家药品监督管理局制定有关药物临床试验等方面的管理政策和技术规范,积极向有关部门提出药物临床试验等方面的建议;努力发展并积极推荐药物临床试验专业委员会成员的科技成果、学术论文及专业著作,促进学会不断发展壮大;全面提升我国药物临床试验领域的知名度和国际竞争力,共创我国药物临床试验技术研究、临床应用、运行管理的最为便捷、实时、互利、互信交流平台。


Drug Clinical Trial Professional  Committee of Chinese Pharmacological Society   

Drug clinical trial professional committee of Chinese Pharmacological Society is mainly devoted to management system construction and academic exchange about drug clinical trial. Many academic leaders and experienced frontline workers in clinical trial field are attracted into the organization as members. The establishment of drug clinical trial committee in China is advantageous to exchange and share valuable experience about the operation management of drug clinical trial among research institutions, improve the quality management system, develop standardized technique evaluation system of the drug clinical trial, encourage international communication and cooperation, and finally promote the progress and development of drug clinical trial in China.Drug clinical trial committee of Chinese Pharmacological Society is mainly devoted to management system construction and academic exchange about drug clinical trial. Many academic leaders and experienced frontline workers in clinical trial field are attracted into the organization as members. The establishment of drug clinical trial committee in China is advantageous to exchange and share valuable experience about the operation management of drug clinical trial among research institutions, improve the quality management system, develop standardized technique evaluation system of the drug clinical trial, encourage international communication and cooperation, and finally promote the progress and development of drug clinical trial in China.

Drug clinical trial professional committee would organize academic exchanges regularly using different forms around the new evaluation techniques and new methods for drug clinical trial, andoperation management of drug clinical trial and so on, in order to explore the operation management mode suitable for Chinese drug clinical trial institutions and set up an international scientific and standardized drug clinical test platform. It is likely to integrate the advantage resources of each drug clinical trial institution, promote the cooperation and resources sharing between each other. Experts in clinical trial field have more opportunities to assist SFDA to formulate management policy and technical specification of the drug clinical trial, put forward advices about drug clinical trial to relevant departments. Drug clinical trial committee is willing to recommend the scientific and technological achievements, academic papers and professional publications of their members, improve the reputation and international competitiveness of Chinese drug clinical trial institution, and finally create a convenient, quick, mutually beneficial exchange platform for technique research, operation management of drug clinical trial in China.